JeffcoatWJ. Should eponyms be actively detached from diseases?Lancet. 2006;367;1296–1297.
2.
KondziellaD. Thirty neurological eponyms associated with the Nazi era. Eur Neurol. 2009;62:56–64.
3.
HallervordenJSpatzH. Eigenartige Erkrankung im extrapyramidalen System mit besonderer Beteiligung des Globus pallidus und der Substantia nigra. Z Gesammte Neurolog Psychiatr. 1922;79:254–302.
4.
ShevellMI. Neurosciences in the Third Reich: from ivory tower to death camps. Can J Neurol Sci. 1999;26:132–138.
5.
ShevellMI.Neurology’s witness to history (part 2): Leo Alexander’s contributions to the Nuremberg code, 1946-47. Neurology. 1988;50:274–278.
6.
ParentSShevellMI. The first to perish: child euthanasia in the Third Reich. Arch Pediatr Adolesc Med. 1988;152:79–86.
7.
ShevellMI. Neurology’s witness to history: the CIOS reports of Leo Alexander. Neurology. 1996;47:1096–1103.
8.
ZeidmanLAPandeyDK.Declining use of the Hallervorden-Spatz disease eponym in the last two decades. J Child Neurol. 2012; 27:1310-1315.
9.
ShevellMI. Racial hygiene, active euthanasia and Julius Hallervorden. Neurology. 1992;42:2214–2219.
10.
TaylorTDLittMKramerP. Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet. 1996;14:79–81.
11.
HayflickSJWestawaySKLevinsonBZhouBMoniqueAJChingKHL. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med. 2003;348:33–40.
12.
ShevellMI. Hallervorden & history. N Engl J Med. 2003;348:3–4.
13.
ShevellMI. Naming of syndromes. Lancet. 1996;348:1662.
